Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications
The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Abstract
Since the discovery of the antiprogestin mifepristone, hundreds of similar compounds have been synthesized, which can be grouped in a large family of progesterone receptor ligands. This family includes pure agonists such as progesterone itself or progestins and, at the other end of the biological spectrum, pure progesterone receptor antagonists (PA). Selective progesterone receptor modulators (SPRM) have mixed agonist-antagonist properties, and occupy an intermediate position of the spectrum. These compounds have numerous applications in female health care. Mifepristone is used to terminate pregnancy, and as such is commercially available in many countries. The negative abortion-related image of mifepristone has clearly limited the involvement of the major pharmaceutical companies in the development of PA and SPRM. Many PA and SPRM display direct antiproliferative effects in the endometrium, although with variable actions which seem product- and dose-dependent. This property justifies their use in the treatment of myomas and endometriosis. PA also suppress late follicular development, block the LH surge and retard endometrial maturation, which renders them potential estrogen-free contraceptive drugs. SPRM such as asoprisnil are not as effective in blocking the LH surge and appear to target the endometrium directly and produce amenorrhoea. Interestingly, clinical data show that treatment with these compounds is not associated with hypo-estrogenism and bone loss. The potential clinical applications of these compounds cover a broad field and are very promising in major public health areas. These include emergency contraception, long-term estrogen-free contraception (administered alone, or in association with a progestin-only pill to improve bleeding patterns), myomas (where they induce a marked reduction in tumour volume and produce amenorrhoea) and endometriosis. Further developments might also include hormone replacement therapy in post-menopausal women, as well as the treatment of hormone-dependent tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SPRMs induce amenorrhea without causing a hypoestrogenic state or associated bone loss (Chabbert-Buffet et al., 2005).”
From Endometriosis and nuclear receptors (2019) · cites this paper as Chabbert-Buffet et al., 2005
Citations
Cites
Noyes, R. W., Hertig, A. T., & Rock, J. (1950) · Fertility and Sterility · doi:10.1016/s0015-0282(16)30062-0 · Cited by 2,843
Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
Hall, J. M., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7179 · Cited by 1,075
Wilcox, A. J., Weinberg, C. R., & Baird, D. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332301 · Cited by 1,070
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Vegeto, E., Shahbaz, M. M., Wen, D. X., Goldman, M. E., O'Malley, B. W., & McDonnell, D. P. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8264658 · Cited by 760
Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform
Mulac-Jericevic, B., Mullinax, R. A., DeMayo, F. J., Lydon, J. P., & Conneely, O. M. (2000) · Science · doi:10.1126/science.289.5485.1751 · Cited by 704
von Hertzen, H., Piaggio, G., Peregoudov, A., Ding, J., Chen, J., Song, S., Bártfai, G., Ng, E., Gemzell-Danielsson, K., Oyunbileg, A., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11767-3 · Cited by 570
Estrogen receptor (ER) β, a modulator of ERα in the uterus
Weihua, Z., Saji, S., Mäkinen, S., Cheng, G., Jensen, E. V., Warner, M., & Gustafsson, J.-Å. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.5936 · Cited by 507
Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair
Gellersen, B., & Brosens, J. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780357 · Cited by 436
Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA
Misrahi, M., Atger, M., d'Auriol, L., Loosfelt, H., Meriel, C., Fridlansky, F., Guiochon-Mantel, A., Galibert, F., & Milgrom, E. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91416-1 · Cited by 418
Progesterone-binding Components of Chick Oviduct
Spelsberg, T. C., Steggles, A. W., & O'Malley, B. W. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62071-x · Cited by 389
Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone
Grunberg, S. M., Weiss, M. H., Spitz, I. M., Ahmadi, J., Sadun, A., Russell, C. A., Lucci, L., & Stevenson, L. L. (1991) · Journal of Neurosurgery · doi:10.3171/jns.1991.74.6.0861 · Cited by 379
Self-citationGiangrande, P. H., & McDonnell, D. P. (1999) · PubMed · Cited by 339
Tung, L., Mohamed, M. K., Hoeffler, J. P., Takimoto, G. S., & Horwitz, K. B. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8123133 · Cited by 324
Nuclear receptor coregulators: multiple modes of modification
Hermanson, O., Glass, C. K., & Rosenfeld, M. G. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00527-6 · Cited by 322
Progesterone-binding Components of Chick Oviduct
Sherman, M. R., Corvol, P. L., & O'Malley, B. W. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62667-5 · Cited by 318
Glasier, A., Thong, K. J., Dewar, M., Mackie, M., & Baird, D. T. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210083271501 · Cited by 310
MURPHY, L. J., & GHAHARY, A. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-3-443 · Cited by 305
Estrogen Regulates the Synthesis of Epidermal Growth Factor in Mouse Uterine Epithelial Cells
Huet-Hudson, Y. M., Chakraborty, C., De, S. K., Suzuki, Y., Andrews, G. K., & Dey, S. K. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-3-510 · Cited by 278
Mote, P. A., Balleine, R. L., McGowan, E. M., & Clarke, C. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5928 · Cited by 270
Mote, P. A., Bartow, S., Tran, N., & Clarke, C. L. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1014820500738 · Cited by 255
Wagner, B. L., Norris, J. D., Knotts, T. A., Weigel, N. L., & McDonnell, D. P. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1369 · Cited by 255
Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy, A. A., Kettel, L. M., Morales, A. J., Roberts, V. J., & Yen, S. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432797 · Cited by 247
McPhail, M. K. (1934) · The Journal of Physiology · doi:10.1113/jphysiol.1934.sp003217 · Cited by 245
Grande, M. A., Kraan, I. V. D., Jong, L. D., & Driel, R. V. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.15.1781 · Cited by 223
Treatment of endometriosis with the antiprogesterone mifepristone (RU486)
Michael Kettel, L., Murphy, A. A., Morales, A. J., Ulmann, A., Baulieu, E. E., & Yen, S. S. C. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58022-4 · Cited by 216
Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.
Webb, A. M., Russell, J., & Elstein, M. (1992) · BMJ · doi:10.1136/bmj.305.6859.927 · Cited by 216
McDonnell, D. P., & Goldman, M. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32664-9 · Cited by 211
Brandon, D. D., Bethea, C. L., Strawn, E. Y., Novy, M. J., Burry, K. A., Harrington, M. S., Erickson, T. E., Warner, C., Keenan, E. J., & Clinton, G. M. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90135-6 · Cited by 207
Cloning and sequence analysis of rabbit progesterone-receptor complementary DNA.
Loosfelt, H., Atger, M., Misrahi, M., Guiochon-Mantel, A., Meriel, C., Logeat, F., Benarous, R., & Milgrom, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.9045 · Cited by 205
Beck, C. A., Weigel, N. L., Moyer, M. L., Nordeen, S. K., & Edwards, D. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4441 · Cited by 205
De Vivo, I., Huggins, G. S., Hankinson, S. E., Lescault, P. J., Boezen, M., Colditz, G. A., & Hunter, D. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192172299 · Cited by 199
Endometrial and Pituitary Responses to the Steroidal Antiprogestin RU 486in Postmenopausal Women
GRAVANIS, A., SCHAISON, G., GEORGE, M., DE BRUX, J., SATYASWAROOP, P. G., BAULIEU, E. E., & ROBEL, P. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-1-156 · Cited by 189
New estimates of the effectiveness of the Yuzpe regimen of emergency contraception
Trussell, J., Rodrı́guez, G., & Ellertson, C. (1998) · Contraception · doi:10.1016/s0010-7824(98)00042-0 · Cited by 187
Low-dose mifepristone for uterine leiomyomata
Eisinger, S. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02511-5 · Cited by 181
Koji, T., Chedid, M., Rubin, J. S., Slayden, O. D., Csaky, K. G., Aaronson, S. A., & Brenner, R. M. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.2.393 · Cited by 181
Comparison of three single doses of mifepristone as emergency contraception: a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)07190-6 · Cited by 180
Sartorius, C. A., Tung, L., Takimoto, G. S., & Horwitz, K. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98344-4 · Cited by 176
Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
Arnett-Mansfield, R. L., DeFazio, A., Wain, G., Jaworski, R. C., Byth, K., Mote, P. A., & Clarke, C. L. (2001) · PubMed · Cited by 174
McDonnell, D. P., Shahbaz, M. M., Vegeto, E., & Goldman, M. E. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90190-2 · Cited by 173
Gregory, C. W. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2960 · Cited by 171
Systematic Review of Mifepristone for the Treatment of Uterine Leiomyomata
Steinauer, J., Pritts, E. A., Jackson, R., & Jacoby, A. F. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000127622.63269.8b · Cited by 166
Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect
Murphy, A. A., Morales, A. J., Michael Kettel, L., & Yen, S. S. C. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57678-x · Cited by 164
Liu, Z., Auboeuf, D., Wong, J., Chen, J. D., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122225699 · Cited by 159
RU 38486: An Original Multifaceted Antihormone in Vivo
(1984) · Adrenal Steroid Antagonism · doi:10.1515/9783110809572-004 · Cited by 159
Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer
Klijn, J. G. M. (2000) · Steroids · doi:10.1016/s0039-128x(00)00195-1 · Cited by 157
Englund, K., Blanck, A., Gustavsson, I., Lundkvist, U., Sjöblom, P., Norgren, A., & Lindblom, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5287 · Cited by 155
Progesterone receptor subtype B is differentially regulated in human endometrial stroma
Wang, H., Critchley, H. O., Kelly, R. W., Shen, D., & Baird, D. T. (1998) · Molecular Human Reproduction · doi:10.1093/molehr/4.4.407 · Cited by 152
Early luteal phase treatment with mifepristone (RU 486) for fertility regulation
Gemzell‐Danielsson, K., Swahn, M. L., Svalander, P. C., & Bygdeman, M. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138157 · Cited by 150
The effect of ovarian steroids on epithelial ciliary beat frequency in the human Fallopian tube
Mahmood, T., Sarıdoğan, E., Smutna, S., Habib, A. M., & Djahanbakhch, O. (1998) · Human Reproduction · doi:10.1093/humrep/13.11.2991 · Cited by 149
Medical Termination of Pregnancy
Christin-Maitre, S., Bouchard, P., & Spitz, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421307 · Cited by 147
Self-citationProgesterone antagonists and progesterone receptor modulators: an overview
Spitz, I. M. (2003) · Steroids · doi:10.1016/j.steroids.2003.08.007 · Cited by 145
Self-citationMechanism of Action of Progesterone Antagonists
Leonhardt, S. A., & Edwards, D. P. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222701104 · Cited by 144
Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486)
Kettel, L. M., Murphy, A. A., Morales, A. J., & Yen, S. S. C. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70316-3 · Cited by 143
Sumoylation of the Progesterone Receptor and of the Steroid Receptor Coactivator SRC-1
Chauchereau, A., Amazit, L., Quesne, M., Guiochon-Mantel, A., & Milgrom, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207148200 · Cited by 142
Greb, R. R., Heikinheimo, O., Williams, R. F., Hodgen, G. D., & Goodman, A. L. (1997) · Human Reproduction · doi:10.1093/humrep/12.6.1280 · Cited by 136
Differential expression of uterine progesterone receptor forms A and B during the menstrual cycle
Mangal, R. K., Wiehle, R. D., Poindexter, A. N., & Weigel, N. L. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00119-2 · Cited by 135
Kumar, N. S., Richer, J., Owen, G. I., Litman, E. S., Horwitz, K. B., & Leslie, K. K. (1998) · PubMed · Cited by 132
Cheon, Y.-P., Li, Q., Xu, X., DeMayo, F. J., Bagchi, I. C., & Bagchi, M. K. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0270 · Cited by 128
Reinsch, R. C., Murphy, A. A., Morales, A. J., & Yen, S. S. C. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70332-9 · Cited by 123
Brenner, R. M. (2003) · Human Reproduction · doi:10.1093/humrep/deg255 · Cited by 123
Attardi, B. J., Burgenson, J., Hild, S. A., Reel, J. R., & Blye, R. P. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00743-2 · Cited by 118 · cited 7×
“The proliferation marker Ki67 was positive in every biopsy with no difference between the 1 mg dose group and the 10 mg dose group (Cameron et al., 2003).”
BackgroundInfluentialBrown, A., Cheng, L., Lin, S., & Baird, D. T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8140 · Cited by 116
Expression of Nuclear Receptors and Cofacotrs in Human Endometrium and Myometrium
Vienonen, A., Miettinen, S., Bläuer, M., MARTIKAINEN, P. M., Tomás, E. I., Heinonen, P. K., & Ylikomi, T. J. (2004) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2003.09.003 · Cited by 115
Chwalisż, K., Brenner, R. M., Fuhrmann, U. U., Hess-Stumpp, H., & Elger, W. (2000) · Steroids · doi:10.1016/s0039-128x(00)00190-2 · Cited by 113
Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy
DeManno, D. A., Elger, W. A. G., Garg, R. C., Lee, R., Schneider, B., Hess‐Stumpp, H., Schubert, G., & Chwalisż, K. (2003) · Steroids · doi:10.1016/j.steroids.2003.09.008 · Cited by 111
Effect of long-term treatment with low-dose mifepristone on the endometrium
Baird, D. T., Brown, A., Critchley, H. O. D., Williams, A. R., Lin, S., & Cheng, L. (2003) · Human Reproduction · doi:10.1093/humrep/deg022 · Cited by 111
Elger, W. A. G. (2000) · Steroids · doi:10.1016/s0039-128x(00)00178-1 · Cited by 109
Zou, A., Marschke, K. B., Arnold, K. E., Berger, E. M., Fitzgerald, P., Mais, D. E., & Allegretto, E. A. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.3.0253 · Cited by 103
Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle
Croxatto, H. B., Salvatierra, A. M., Croxatto, H. D., & Fuentealba, B. (1993) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138022 · Cited by 103
Nonsurgical mid‐trimester termination of pregnancy: a review of 500 consecutive cases
Ashok, P. W., & Templeton, A. (1999) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08371.x · Cited by 101
Progesterone and RU486: opposing effects on human sperm.
Yang, J., Serres, C., Philibert, D., Robel, P., Baulieu, E. E., & Jouannet, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.529 · Cited by 99
Perrault, D., Eisenhauer, E. A., Pritchard, K. I., Panasci, L., Norris, B., Vandenberg, T., & Fisher, B. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2709 · Cited by 99
The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial.
Romieu, G., Maudelondé, T., Ulmann, A., Pujol, H., Grenier, J., Cavalie, G., Khalaf, S., & Rochefort, H. (1987) · PubMed · Cited by 98
Ortiz, M. (2004) · Human Reproduction · doi:10.1093/humrep/deh180 · Cited by 94
Estrogen action in the reproductive tract of rhesus monkeys during antiprogestin treatment
Slayden, O. D., Hirst, J. J., & Brenner, R. (1993) · Endocrinology · doi:10.1210/endo.132.4.8462480 · Cited by 93
Li, A. J., Baldwin, R. L., & Karlan, B. Y. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.328 · Cited by 93
Subnuclear Distribution of Progesterone Receptors A and B in Normal and Malignant Endometrium
Arnett-Mansfield, R. L., DeFazio, A., Mote, P. A., & Clarke, C. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031111 · Cited by 92
A Randomized Trial of Mifepristone (10 mg) and Levonorgestrel for Emergency Contraception
Hamoda, H., Ashok, P. W., Stalder, C., Flett, G. M. M., Kennedy, E., & Templeton, A. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000146286.60138.47 · Cited by 89
Kettel, L. M., Murphy, A. A., Morales, A. J., et al. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56214-1 · Cited by 88
The Endocrine Effects of Long-Term Treatment with Mifepristone (RU 486)
LAMBERTS, S. W. J., KOPER, J. W., & de JONG, F. H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-1-187 · Cited by 82
Development of the selective progesterone receptor modulator CDB-2914 for clinical indications
Blithe, D., Nieman, L. K., Blye, R. P., Stratton, P., & Passaro, M. (2003) · Steroids · doi:10.1016/s0039-128x(03)00118-1 · Cited by 82
Antiprogestins: Mechanism of Action and Contraceptive
Spitz, I. M., Croxatto, H. B., & Robbins, A. (1996) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000403 · Cited by 82
Self-citationLong‐term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia
Newfield, R. S., Spitz, I. M., Isacson, C., & New, M. I. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01026.x · Cited by 81
Self-citationCameron, S. T., Critchley, H., Thong, K. J., et al. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019151 · Cited by 81
Cheng, L., Zhu, H., Wang, A., et al. (2000) · Human Reproduction · doi:10.1093/humrep/15.9.1969 · Cited by 80
Medical abortion in early pregnancy: A review of the evidence
Grimes, D. A. (1997) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(97)81439-1 · Cited by 79
Role of antiprogestational therapy for meningiomas
Grunberg, S. M. (1994) · Human Reproduction · doi:10.1093/humrep/9.suppl_1.202 · Cited by 79
Slayden, O. D. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.440 · Cited by 77
Effects of progesterone on growth factor expression in human uterine leiomyoma
Maruo, T., Matsuo, H., Shimomura, Y., Kurachi, O., Gao, Z., Nakago, S., Yamada, T., Chen, W., & Wang, J. (2003) · Steroids · doi:10.1016/j.steroids.2003.08.017 · Cited by 77
Bone mass in endometriosis patients treated with GnRH agonist implant or danazol.
Dodin, S., Lemay, A., Maheux, R., Dumont, M., & Turcot-Lemay, L. (1991) · PubMed · Cited by 75
Low-Dose Mifepristone Inhibits Endometrial Proliferation and Up-Regulates Androgen Receptor
Narvekar, N., Cameron, S., Critchley, H. O. D., Lin, S., Cheng, L., & Baird, D. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031945 · Cited by 74
Misrahi, M., Loosfelt, H., Atger, M., Mériel, C., Zerah, V., Dessen, P., & Milgrom, E. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.12.5459 · Cited by 73
Endometrial effects of long-term low-dose administration of RU486
Murphy, A. A., Kettel, L. M., Morales, A. J., Roberts, V. J., Parmley, T. H., & Yen, S. S. C. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57478-0 · Cited by 71
Progesterone receptor modulators and progesterone antagonists in women's health
Spitz, I. M., & Chwalisz, K. (2000) · Steroids · doi:10.1016/s0039-128x(00)00194-x · Cited by 69
Self-citationHan, S., & Sidell, N. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020876 · Cited by 66
Ashok, P. W., Stalder, C. M., Wagaarachchi, P. T., Flett, G. M. M., Melvin, L., & Templeton, A. (2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2002.01371.x · Cited by 64
TSENG, L., MAZELLA, J., & SUN, B. (1986) · Endocrinology · doi:10.1210/endo-118-4-1312 · Cited by 63
Grow, D. R. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1933 · Cited by 60
Wagner, B. L., Pollio, G., Leonhardt, S. A., Wani, M. C., Lee, D. Y., Imhof, M. O., Edwards, D., Cook, C. E., & McDonnell, D. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8739 · Cited by 60
Brenner, R. M., Slayden, O. D., & Critchley, H. O. (2002) · Reproduction · doi:10.1530/rep.0.1240167 · Cited by 60
A randomized double-blind comparison of two single doses of mifepristone for emergency contraception
Xiao, B. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3084 · Cited by 60
Akahira, J., Inoue, T., Suzuki, T., Ito, K., Konno, R., Sato, S., Moriya, T., Okamura, K., Yajima, A., & Sasano, H. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1463 · Cited by 59
Effects of long-term low-dose mifepristone on reproductive function in women
Croxatto, H. B., Kovács, L., Massai, R., et al. (1998) · Human Reproduction · doi:10.1093/humrep/13.4.793 · Cited by 59
Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models
Hodgen, G. D., van Uem, J. F. H. M., Chillik, C. F., Danforth, D. R., Wolf, J. P., Neulen, J., Williams, R. F., & Chwalisz, K. (1994) · Human Reproduction · doi:10.1093/humrep/9.suppl_1.77 · Cited by 56
Expression of Progesterone Receptor Form A and B mRNAs in Gynecologic Malignant Tumors
Fujimoto, J., Ichigo, S., Hori, M., Nishigaki, M., & Tamaya, T. (1995) · Tumor Biology · doi:10.1159/000217942 · Cited by 55
Contraceptive efficacy of low doses of mifepristone
Marions, L., Gemzell‐Danielsson, K., Swahn, M. L., et al. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00306-9 · Cited by 54
Mifepristone. Auxiliary therapeutic use in cancer and related disorders.
KOIDE, S. S. (1998) · PubMed · Cited by 53
Feasibility of administering mifepristone as a once a month contraceptive pill
Hapangama, D. K. (2001) · Human Reproduction · doi:10.1093/humrep/16.6.1145 · Cited by 51
Sonographic assessment of the endometrium in osteopenic postmenopausal women treated with idoxifene.
Fleischer, A. C., Wheeler, J. E., Yeh, I., Kravitz, B. G., Jensen, C., & MacDonald, B. (1999) · Journal of Ultrasound in Medicine · doi:10.7863/jum.1999.18.7.503 · Cited by 50
Flutamide Counteracts the Antiproliferative Effects of Antiprogestins in the Primate Endometrium
Slayden, O. D., & Brenner, R. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021763 · Cited by 49
Lundeen, S. G., Zhang, Z., Zhu, Y., Carver, J. M., & Winneker, R. C. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00091-7 · Cited by 49
Gemzell‐Danielsson, K. (2002) · Human Reproduction · doi:10.1093/humrep/17.10.2588 · Cited by 47
Zelinski, M. B., Slayden, O. D., Chwallsz, K., et al. (1998) · Human Reproduction · doi:10.1093/humrep/13.2.259 · Cited by 47
Ottander, U., Hosokawa, K., Liu, K., et al. (2000) · Biology of Reproduction · doi:10.1095/biolreprod62.3.655 · Cited by 42
Mifepristone as a late post-coital contraceptive
Ashok, P. W., Wagaarachchi, P. T., Flett, G. M. M., & Templeton, A. (2001) · Human Reproduction · doi:10.1093/humrep/16.1.72 · Cited by 41
The use of progesterone antagonists and progesterone receptor modulators in contraception
Spitz, I. M. (2000) · Steroids · doi:10.1016/s0039-128x(00)00199-9 · Cited by 41
Self-citationRU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri
Murphy, A. A., & Castellano, P. Z. (1994) · Current Opinion in Obstetrics and Gynecology · doi:10.1097/00001703-199406000-00012 · Cited by 39
Permezel, J., Lenton, E. A., Roberts, I. M., et al. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-5-960 · Cited by 39
Heikinheimo, O., Ranta, S., Grunberg, S. M., Lähteenmäki, P., & Spitz, I. M. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90256-0 · Cited by 38
Self-citationContraceptive efficacy of daily administration of 0.5 mg mifepristone
Marions, L., Viski, S., Gemzell‐Danielsson, K., et al. (1999) · Human Reproduction · doi:10.1093/humrep/14.11.2788 · Cited by 38
Progesterone Receptor A and B Isoforms in the Human Breast and Its Disorders
Ariga, N., SUZUKI, T. A., Moriya, T., et al. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01095.x · Cited by 37
Neulen, J., Williams, R. F., Breckwoldt, M., et al. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019433 · Cited by 36
Treatment of Large Fibroids with High Doses of Gestrinone
Coutinho, E. M. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000293212 · Cited by 35
Estrogenic effects of the antiprogestin onapristone (ZK98.299) in the rodent uterus
Bigsby, R. M., & Young, P. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(94)90468-5 · Cited by 35
Fibroid growth in response to high-dose progestogen
Harrison‐Woolrych, M., & Robinson, R. E. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57679-1 · Cited by 35
Modulation of oestrogenic effects by progesterone antagonists in the rat uterus
Chwalisż, K., Stöckemann, K., Fritzemeier, K. H., & Fuhrmann, U. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.5.570 · Cited by 34
Stoeckemann, K., Hegele-Hartung, C., & Chwalisz, K. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135900 · Cited by 33
Heikinheimo, O., Hsiu, J.-G., Gordon, K., Kim, S., Williams, R. F., Gibbons, W. E., & Hodgen, G. D. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00113-6 · Cited by 33
Grow, D. R., Reece, M. T., Hsiu, J. G., Adams, L. A., Newcomb, P. M., Williams, R. F., & Hodgen, G. D. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00029-6 · Cited by 32
Once-a-month treatment with a combination of mifepristone and the prostaglandin analogue misoprostol
Swahn, M. L., Bygdeman, M., Jun-kang, C., et al. (1999) · Human Reproduction · doi:10.1093/humrep/14.2.485 · Cited by 31
World Health Organization Task Force on Post-ovulatory Methods of Fertility Regulation (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135933 · Cited by 31
Contraceptive use of antiprogestin
Bygdeman, M., Gemzell‐Danielsson, K., Marions, L., et al. (1999) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189909064011 · Cited by 30
Zeng, C., Gu, M., & Huang, H. H. (1998) · PubMed · Cited by 29
Liedman, R., Lindahl, B., Andolf, E. G., et al. (2001) · PubMed · Cited by 27
Messinis, I. E., & Templeton, A. A. (1988) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1988.tb09489.x · Cited by 26
Croxatto, H. B., Salvatierra, A. M., Fuentealba, B., et al. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136221 · Cited by 26
Artificial induction of the acrosome reaction in human spermatozoa
Gearon, C. M., Mortimer, D., CHAPMAN, M. G., et al. (1994) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138324 · Cited by 25
[Treatment of uterine leiomyoma by two different doses of mifepristone].
Yang, Y., Zheng, S., & Li, K. (1996) · PubMed · Cited by 24
Mechanisms of action of mifepristone when used for emergency contraception
Gemzell‐Danielsson, K., Mandl, I., & Marions, L. (2003) · Contraception · doi:10.1016/s0010-7824(03)00070-2 · Cited by 21
Morphology of the rat uterus after long-term treatment with progesterone antagonists
Rumpe, E., Michna, H., & Kühne, W. (1993) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/s0940-9602(11)80170-6 · Cited by 21
THE POTENTIAL OF MIFEPRISTONE (RU486) AS A FEMALE CONTRACEPTIVE DRUG
Sarkar, N. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11212.x · Cited by 21
Piaggio, G. G., von Hertzen, H., Heng, Z., Bilian, X., & Cheng, L. (2003) · Contraception · doi:10.1016/s0010-7824(03)00142-2 · Cited by 20
RU486 is a potent inhibitor of aromatase induction in human breast adipose tissue stromal cells
Schmidt, M., & Löffler, G. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00178-1 · Cited by 18
Kahmann, S., Vaßen, L., & Klein‐Hitpaß, L. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.2.0067 · Cited by 18
Heikinheimo, O. (2000) · Steroids · doi:10.1016/s0039-128x(00)00196-3 · Cited by 15
Mifepristone for luteal phase contraception
Croxatto, H. B. (2003) · Contraception · doi:10.1016/s0010-7824(03)00182-3 · Cited by 14
Large endometrial polyp in a patient on long-term mifepristone therapy.
Martineau, P. A., & Levental, M. (2000) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2000.19.7.487 · Cited by 13
Effects of onapristone on postmenopausal endometrium
Cameron, S. T., Glasier, A. F., Narvekar, N. N., Gebbie, A. E., Critchley, H., & Baird, D. T. (2003) · Steroids · doi:10.1016/j.steroids.2003.07.004 · Cited by 12
Borman, S. M., Schwinof, K. M., Niemeyer, C., et al. (2003) · Human Reproduction · doi:10.1093/humrep/deg014 · Cited by 12
The possible use of antiprogestins for contraception.
Bygdeman, M., Gemzell‐Danielsson, K., & Ml, S. (1997) · PubMed · Cited by 11
New progestins and potential actions
Negro-Vilar, A. F. (2000) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(99)00056-8 · Cited by 8
Spitz, I. M. (2000) · Steroids · doi:10.1016/s0039-128x(00)00186-0 · Cited by 6
Self-citationSpitz, I. M. (2000) · Steroids · Cited by 4
Self-citationNew Progestins and Potential Actions
Negro-Vilar, A. F. (2000) · Journal of the Society for Gynecologic Investigation · doi:10.1177/1071557600007001s14 · Cited by 3
Research works printed but not linked: 28
- 2001, Cancer Res, 61, 4576
- 2001, Hum Reprod, 16, 72
- 1997, Acta Obstet Gynecol Scand Suppl, 164, 75
- 2002, J Soc Gynecol Invest, 9
- 2003, J Soc Gynecol Invest, 10, 301A
- 1991, Obstet Gynecol, 77, 410
- 2003, Obstet Gynecol, 101, 243
- 1998, J Clin Endocrinol Metab, 83, 4092
- 1999, Recent Prog Horm Res, 291
- 2002, J Clin Endocrinol Metab, 87, 2960, 10.1210/jcem.87.6.8572 · doi:10.1210/jcem.87.6.8572 · Paper page
- 1996, J Clin Endocrinol Metab, 81, 1933
- 1994, Hum Reprod, 9, 202
- 1994, Hum Reprod, 9, 77
- 1998, Mol Endocrinol, 12, 278
- 1998, J Reprod Med, 43, 551
- 1998, Cancer Res, 58, 1860
- 2000, Anticancer Res, 20, 4889
- 1999, J Clin Endocrinol Metab, 84, 2963
- 1993, J Clin Endocrinol Metab, 76, 513
- 1994, Am J Obstet Gynecol, 170, 1623, 10.1016/S0002-9378(12)91826-8 · doi:10.1016/s0002-9378(12)91826-8
- 1987, Bull Cancer, 74, 455
- 1994, J Clin Endocrinol Metab, 78, 440
- 1993, Mol Endocrinol, 7, 1256
- 1993, Mol Endocrinol, 7, 1244
- 1996, Chin J Obstet Gynecol, 31, 624
- 1998, Hum Reprod, 13, 259
- 1998, Zhonghua Fu Chan Ke Za Zhi, 33, 490
- 1999, Mol Endocrinol, 13, 418
Cited by
The Methylation Effect in Medicinal Chemistry
Barreiro, E. J., Kümmerle, A. E., & Fraga, C. A. M. (2011) · Chemical Reviews · doi:10.1021/cr200060g · Cited by 1,017
Uterine fibroid management: From the present to the future
Donnez, J., & Dolmans, M.-M. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw023 · Cited by 780
Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery
Donnez, J., Tatarchuk, T. F., Bouchard, P., Puscasiu, L., Zakharenko, N. F., Ivanova, T., Ugocsai, G., Mara, M., Jilla, M. P., Bestel, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1103182 · Cited by 680
Self-citationProgesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
The kisspeptin-GnRH pathway in human reproductive health and disease
Skorupskaite, K., George, J. T., & Anderson, R. A. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu009 · Cited by 500
Metadata
- Authors
- Chabbert-Buffet, N., Meduri, G., Bouchard, P., & Spitz, I. M.
- ORCID
- Bouchard, Philippe
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-01
- Volume
- 11
- Issue
- 3
- Pages
- 293-307
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2147700987
- Cited by
- 310
- References
- 156
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 12 · 2020: 11 · 2019: 16 · 2018: 14 · 2017: 23 · 2016: 17 · 2015: 20 · 2014: 23 · 2013: 20 · 2012: 19
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction Update (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- selective progesterone receptor modulators, antiprogestins, mifepristone, asoprisnil, uterine fibroids, endometriosis, emergency contraception, amenorrhea, bone loss, hormone replacement therapy, hormone-dependent tumors, abortion
- MeSH terms
- Endometriosis, Estrenes, Female, Gonanes, Humans, Leiomyoma, Norpregnadienes, Oximes, Oxytocics, Progesterone, Receptors, Progesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.